HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MicroRNA-155 attenuates late sepsis-induced cardiac dysfunction through JNK and β-arrestin 2.

Abstract
Cardiac dysfunction is correlated with detrimental prognosis of sepsis and contributes to a high risk of mortality. After an initial hyperinflammatory reaction, most patients enter a protracted state of immunosuppression (late sepsis) that alters both innate and adaptive immunity. The changes of cardiac function in late sepsis are not yet known. MicroRNA-155 (miR-155) is previously found to play important roles in both regulations of immune activation and cardiac function. In this study, C57BL/6 mice were operated to develop into early and late sepsis phases, and miR-155 mimic was injected through the tail vein 48 h after cecal ligation and puncture (CLP). The effect of miR-155 on CLP-induced cardiac dysfunction was explored in late sepsis. We found that increased expression of miR-155 in the myocardium protected against cardiac dysfunction in late sepsis evidenced by attenuating sepsis-reduced cardiac output and enhancing left ventricular systolic function. We also observed that miR-155 markedly reduced the infiltration of macrophages and neutrophils into the myocardium and attenuated the inflammatory response via suppression of JNK signaling pathway. Moreover, overexpression of β-arrestin 2 (Arrb2) exacerbated the mice mortality and immunosuppression in late sepsis. Furthermore, transfection of miR-155 mimic reduced Arrb2 expression, and then restored immunocompetence and improved survival in late septic mice. We conclude that increased miR-155 expression through systemic administration of miR-155 mimic attenuates cardiac dysfunction and improves late sepsis survival by targeting JNK associated inflammatory signaling and Arrb2 mediated immunosuppression.
AuthorsYu Zhou, Yan Song, Zahir Shaikh, Hui Li, Haiju Zhang, Yi Caudle, Shouhua Zheng, Hui Yan, Dan Hu, Charles Stuart, Deling Yin
JournalOncotarget (Oncotarget) Vol. 8 Issue 29 Pg. 47317-47329 (Jul 18 2017) ISSN: 1949-2553 [Electronic] United States
PMID28525390 (Publication Type: Journal Article)
Chemical References
  • Cytokines
  • Inflammation Mediators
  • MicroRNAs
  • Mirn155 microRNA, mouse
  • beta-Arrestin 2
  • JNK Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Gene Expression
  • Gene Expression Regulation
  • Heart Diseases (etiology, metabolism, mortality, physiopathology)
  • Heart Function Tests
  • Humans
  • Inflammation Mediators (metabolism)
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Macrophages (metabolism)
  • Male
  • Mice
  • MicroRNAs (genetics)
  • Myocardium (metabolism)
  • Neutrophils (metabolism)
  • RNA Interference
  • Sepsis (complications, etiology)
  • Signal Transduction
  • Survival Rate
  • Transfection
  • beta-Arrestin 2 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: